ghp June 2015

inside this issue this month’s features editor’s note “Despite its size and potential, the UK specialist care sector is highly fragmented, in which the top 10 providers control more than 15% of the market and in excess of 81% of assets lie outside of the top 16 operators.” Oliver Harris, Managing Partner, Montreux Capital Management, p10 Stem Cells Might Expand Window for Treating Stroke A recent study in stem cells could open the door to a new therapy to potentially expand the current win- dow of time for treating patients af- ter they have experienced a stroke. Page 26 Surgical Robots Market Worth $20 Billion by 2021 Research report says surgical robot device markets anticipated to reach $20 billion by 2021 as next generation devices, systems, and instruments are introduced to manage surgery through small ports in the body. Page 36 04 News 10 UK Private Healthcare Sector Poised for Wave of M&A 14 Takling the ‘Weekday Effect’ 18 Merck Serono Takes Leading Role in Fertility Technologies 20 30 Minutes to Save a Life: Doc Uses Social Network to Diagnose Fatal Condition 22 Interoperability among Connected Medical Devices Can Potentially TransformHealthcare 24 SurgiQuest’s AirSeal ® System Receives FDA 510(k) Clearance for Transanal Endoscopic Surgery 28 Dassault Systèmes Announces Commercial Availability of its First Simulated Human Heart 30 Is There Such a Thing as ‘Healthcare 4.0’? 34 InNewCardiac Surgery Study NephroCheck ® Kidney Biomarkers Rise to the Occasion 38 Poll: Many Americans Know Some- oneWho Has Abused Prescription Painkillers and SufferedMajor Harmful Effects 40 CanUAE Reach Ambitious 2021 Health Goals? 42 Johns Hopkins Bloomberg School of Public Health to Lead $17Million Canadian Project 44 Ongoing Challenges in Identifying and Tackling Food Fraud Are Vital to Safeguarding Public Health Global Health & Pharma, 39A Birmingham Road, Blakedown, Worcestershire, DY10 3JW Tel: +44 (0) 1234 567 890 | Email: [email protected] | Web: Welcome to the latest issue of Global Health & Pharma Magazine. This month, we look at whether UAE looks likely to reach its ambitious healthcare goals by 2021 and we take a closer look at a scientifically accurate 3d model that accelerates device testing and research for the treatment of heart disease. We speak to Dan Somers of Warwick Ana- lytics about how far data-driven operations and Predictive Analytics in the healthcare industry has come, and find out from Oliver Harris, Managing Partner at Montreux Capital Management, why the UK health- care industry is poised for a wave of M&A. There’s a report on the future of the surgical robots industry and why it is set to be worth an eyewatering $20 billion by 2021 and an exciting look at how stem cells could open the door for faster, more effective treatments for patients who have experienced a stroke. Not only this but Nick Simpson, CEO of MSI Group, talks to us about tackling the’ weekend effect’ and we hear about how a popular US-based social network helped a doctor save the life of a 14-year-old boy. Plus we have all the usual news and comment from around the global healthcare and pharmaceutical industries. We hope you enjoy the issue. Mark Toon, Editor